Authors

Latest:

Disruption is the order of the day to create a more individual-centric hub experience from the patient’s point of view

Latest:

***Live: Thursday, February 25, 2021 at 11am EST | 8am PST | 4pm GMT | 5pm CET*** As strategic planning among manufacturers and logistics partners commences, this webinar will serve as a platform to discuss service offerings and explore the most effective possible solutions. *** On demand until Feb. 25, 2022**

Latest:

What stands between pharma and other industries when it comes to remaining vigilant?

Latest:

While often portrayed in a negative light, it is important to find a balanced perspective on its role in the pharma sector.

Latest:

Examining the divestment risks, as more large companies look to spin off consumer health and other business units to focus on branded pharmaceuticals

Latest:

As the State Drug Pricing Transparency Program expands, what does that mean for manufacturers? Jesse Mendelsohn, Vice President, Centers of Excellence for Model N, the leader in cloud revenue management solutions for life science companies, discusses challenges for manufacturers as the State Price Transparency Program expands how they should plan for this change and the solutions they will need.

Latest:

Vendor relationships are best supported by practices that emphasize efficiency, visibility, and the streamlining of the invoice to pay process

Latest:

If manufacturers cannot ensure safe, cost-effective delivery of treatments for rare diseases, access will remain a challenges for many patients living with these conditions.

Latest:

Drug shortages are inevitable—being caught off guard isn’t. The best ways distributors can use and position data to drive today’s inventory solutions

Latest:

Biosimilars market experiences massive growth, but regulatory and adoption challenges remain.

Latest:

Boehringer Ingelheim’s unbranded adalimumab-adbm biosimilar will be available at an 81% discount to adalimumab (Humira).

Latest:

How CDMOs will lead the way toward true cloud lab enablement

Latest:

The latest news for pharma industry insiders.

Latest:

The Identification of Medicinal Product framework seeks to establish a common language for identifying, documenting, and exchanging information about medicinal products.

Latest:

Outlining the work of the Open Credentialing Initiative in establishing digital proof of identity, licensure status, and authorship using digital wallets and verifiable credentials

Latest:

Pharma compliance requires stringent quality assurance in order to ensure patient safety, but the default for many pharma companies is still to use manual processes for supplier vetting and reporting. Gaëlle Jaron looks at how the food industry might inspire pharma to transform its processes

Latest:

Given the biopharma sector‘s complex set of networks and supply chains, so it is not straightforward to shift towards net zero across all operations.

Latest:

Latest:

An exploration of the new demands in cold-chain visibility and sustainability—and the resulting tech-driven efforts to address them—leads off our coverage in this month's issue.

Latest:

The benefits of hybrid direct-to-patient studies and supply chain structures in boosting drug access, influencing clinical trial design

Latest:

Offer potential to improve patient care, including in medication adherence.

Latest:

How cross-functional commercialization teams can hone their role within clinical management pathways, communicate value to all stakeholders, achieve excellence in evidence generation, and maximize the opportunities of digital technologies

Latest:

Precision-based diagnostic approaches can help us improve patient outcomes and reach patient success sooner

Latest:

Delivering a first-class patient engagement approach is complex enough in a large pharma market. For smaller European markets, it can be even more challenging. Ian Riches looks at how pharma companies can put all patients at the center of their engagement plans, no matter which country they live in.

Latest:

What makes a third-party logistics provider independent?

Latest:

The UK‘s imminent CO2 shortage crisis is second time in less than a year that CO2 shortages have threatened critical cold chains. As the demand for COVID-19 vaccines, mRNA-based therapies and precision medicine treatments grows, organizations will have to rethink their ultra-low temperature (ULT) strategies to prevent these shortages from impacting the pharma cold chain, writes Shea Vincent.

Latest:

The era of big pharma as product-first companies must end, as services become the larger priority.

Latest:

Best practices for pharmacies in storage, monitoring and maintenance of their Covid vaccine shipments

Latest:

When shipping pharmaceuticals internationally, the decision of ocean shipping versus air shipping might seem obvious if the speed of air shipping is the only factor at play when sending sensitive medical supplies and drugs. For the last several years, however, more companies have decided to embrace ocean shipping as a means of delivering their medicines. Industry experts Alan Kennedy and Allan Klinge discuss how, with more cold chain control, a lower carbon footprint and lower costs, ocean-going vessels often have clear advantages over air freight.